Bharat Serums and Vaccines Limited (BSV) was set up in 1971 to pursue an ambitious goal of introducing specialized healthcare products to meet the needs of a quality conscious market. The company has been manufacturing and marketing biological, pharmaceutical and biotechnology products, ever since.
Today, BSV holds a formidable market share in India for plasma derivatives, and is constantly expanding its range of products by introducing new and improved therapies based on strong R&D initiatives and efforts.
- Sepsis is the body’s systemic inflammatory and coagulopathic response to microbial infection (in the blood, urine, lungs, skin, or other tissues) that often progresses to a severe form manifested by multiple organs.
- Sepsis is regarded as one of the leading causes of death throughout the world.
- India’s First Ulinastatin containing
formulation for Sepsis Management.
U-Tryp provides the following benefits in Sepsis:
- Reduces mortality in severe sepsis patients.
- Reduces duration of mechanical ventilation and hospital stay thus reducing cost of care